Tarsus Pharmaceuticals had a revenue of 78.33M in the quarter ending Mar 31, 2025, with 17.96%. This bring the company's revenue in the last twelve months to 233.67M, Decreased 27.72%. In the fiscal year ending Dec 31, 2024, Tarsus Pharmaceuticals had annual revenue of 182.95M with 948.62% growth.